Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs)
Related Experiment Video
Updated: May 19, 2026

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
Daniel Holzinger1, Rudolf Seemann, Clemens Klug
1University Clinic of Craniofacial, Maxillofacial and Oral Surgery, Medical University of Vienna, Austria. daniel.holzinger@meduniwien.ac.at
Objectives:
Bisphosphonates are associated with osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) may be treated conservatively or by surgery.
Patients And Methods:
108 patients underwent surgery and 88 patients were followed for a mean period of 337 days. Age, gender, dental procedures, underlying disease, and the role of bisphosphonate treatment in the success of surgery were evaluated retrospectively.
Results:
Surgical treatment improved the stage distribution from 19% stage I, 56% stage II and 25% stage III to 59% intact mucosa, 19% stage I and 13% stage II and 8% stage III. The improvement in the stage of disease achieved by surgery was statistically significant. Further relevant parameters that favor a positive outcome of surgery were the event triggering the outbreak of BRONJ (p=0.05) and the underlying disease (p=0.05). BRONJ in the maxilla necessitated repeat surgery significantly earlier than did BRONJ in the mandible (p=0.03).
Conclusion:
Effective surgery might improve the outcome of BRONJ, although prevention still is the most important aspect of this condition.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Urinary Tract Calculi VI: Surgical Management
